TipRanks
Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
US Market

Compare Anthera Pharmaceuticals (ANTH) vs. Competitors

238 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Anthera Pharmaceuticals
<$0.01
$2.62K
―
66.67%
―
Can-Fite BioPharma
$3.32
$6.47M
-0.30
-81.98%
1 Buy
0 Hold
0 Sell
Moderate Buy
RedHill Biopharma
$1.20
$2.92M
-0.24
-80.95%
―
Akari Therapeutics
$7.87
$16.28M
>-0.01
-77.45%
3 Buy
0 Hold
0 Sell
Strong Buy
Pulmatrix
$1.52
$5.55M
-1.39
-68.54%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ANTH
Anthera Pharmaceuticals
―
―
―
CANF
Can-Fite BioPharma
2.21
-9.91
-81.76%
GLMD
―
―
―
―
RDHL
RedHill Biopharma
0.48
-1.74
-78.38%
AKTX
Akari Therapeutics
8.84
-28.51
-76.33%
PULM
Pulmatrix
1.54
-3.33
-68.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts